AR020055A1 - Una composicion farmaceutica o cosmetica que contiene una sustancia de esmalte activa, usos de dicha composicion y un metodo para preparar la misma. - Google Patents
Una composicion farmaceutica o cosmetica que contiene una sustancia de esmalte activa, usos de dicha composicion y un metodo para preparar la misma.Info
- Publication number
- AR020055A1 AR020055A1 ARP990100872A ARP990100872A AR020055A1 AR 020055 A1 AR020055 A1 AR 020055A1 AR P990100872 A ARP990100872 A AR P990100872A AR P990100872 A ARP990100872 A AR P990100872A AR 020055 A1 AR020055 A1 AR 020055A1
- Authority
- AR
- Argentina
- Prior art keywords
- pharmaceutical
- substance
- composition
- prepare
- same
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/10—Polypeptides; Proteins
- A61L24/108—Specific proteins or polypeptides not covered by groups A61L24/102 - A61L24/106
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0028—Polypeptides; Proteins; Degradation products thereof
- A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/906—Drug delivery
Abstract
Una Composicion farmacéutica o cosmética que contiene una sustancia de esmalte activa, composicion que comprende una sustancia de esmalte activaseleccionada del grupo formado por matriz de esmalte, derivados de matriz de esmalte y/o proteínas de matriz de esmalte. La composicion farmacéutica ocosmética de esta invencion puede ser usada para cicatrizar una herida, mejorar la cicatrizacion de una herida, regenerar o reparar tejidos blandos o preveniry/o tratar una infeccion. Método para la preparacion de dichas composiciones farmacéuticas o cosméticas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK27098 | 1998-02-27 | ||
DKPA199801328 | 1998-10-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR020055A1 true AR020055A1 (es) | 2002-04-10 |
Family
ID=34395112
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP990100872A AR020055A1 (es) | 1998-02-27 | 1999-03-02 | Una composicion farmaceutica o cosmetica que contiene una sustancia de esmalte activa, usos de dicha composicion y un metodo para preparar la misma. |
Country Status (6)
Country | Link |
---|---|
US (3) | US6503539B2 (es) |
JP (1) | JP4726296B2 (es) |
AR (1) | AR020055A1 (es) |
BR (1) | BRPI9908182C1 (es) |
PL (1) | PL204797B1 (es) |
RU (1) | RU2241489C2 (es) |
Families Citing this family (82)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1248734C (zh) * | 1998-02-27 | 2006-04-05 | 拜奥拉拜奥爱克斯公司 | 用于伤口愈合的基质蛋白组合物 |
US6884427B1 (en) * | 1999-02-08 | 2005-04-26 | Aderans Research Institute, Inc. | Filamentary means for introducing agents into tissue of a living host |
US6979670B1 (en) * | 1999-03-10 | 2005-12-27 | Biora Bioex Ab | Matrix protein compositions for grafting |
US20030096740A1 (en) * | 1999-03-10 | 2003-05-22 | Lars Hammarstrom | Matrix protein compositions for induction of apoptosis |
NZ517706A (en) | 1999-10-08 | 2004-01-30 | Affinium Pharm Inc | Fab I inhibitors |
US6821953B1 (en) * | 1999-12-16 | 2004-11-23 | University Of Southern California | Methods for treating and preventing damage to mucosal tissue |
JP5095063B2 (ja) * | 2000-06-20 | 2012-12-12 | ストローマン ホールディング アーゲー | 象牙質再生に用いる基質タンパク質組成物 |
US7304030B2 (en) * | 2000-06-20 | 2007-12-04 | Biora Ab | Matrix protein composition for dentin regeneration |
JP4017977B2 (ja) * | 2000-08-08 | 2007-12-05 | アデランス リサーチ インスティテュート インコーポレイテッド | 組織工学で処置した毛髪用の台 |
US7144729B2 (en) | 2000-09-01 | 2006-12-05 | Dfb Pharmaceuticals, Inc. | Methods and compositions for tissue regeneration |
US20040018228A1 (en) * | 2000-11-06 | 2004-01-29 | Afmedica, Inc. | Compositions and methods for reducing scar tissue formation |
CA2434254C (en) * | 2001-01-12 | 2013-08-13 | Board Of Regents, The University Of Texas System | Novel antiseptic derivatives with broad spectrum antimicrobial activity for the impregnation of surfaces |
US7033611B2 (en) * | 2001-02-23 | 2006-04-25 | Biora Bioex Ab | Matrix protein compositions for guided connective tissue growth |
ES2320984T3 (es) * | 2001-04-06 | 2009-06-01 | Affinium Pharmaceuticals, Inc. | Inhibidores de fab i. |
BR0212527A (pt) * | 2001-09-14 | 2004-10-19 | Biora Bioex Ab | Composições de proteìna de matriz esmaltada para modulação de resposta imune |
WO2003061506A2 (en) | 2002-01-23 | 2003-07-31 | Dentsply International, Inc. | Irrigation solution and methods for use |
US20040068284A1 (en) * | 2002-01-29 | 2004-04-08 | Barrows Thomas H. | Method for stimulating hair growth and kit for carrying out said method |
JP4948744B2 (ja) * | 2002-10-04 | 2012-06-06 | 允 深江 | 歯周組織再生剤、その有効成分抽出法、およびプラスミド |
CA2508792C (en) * | 2002-12-06 | 2013-02-05 | Affinium Pharmaceuticals, Inc. | Heterocyclic compounds, methods of making them and their use in therapy |
JP2004307454A (ja) * | 2003-02-21 | 2004-11-04 | Seikagaku Kogyo Co Ltd | 生理活性ペプチド及びこれを含有する薬剤 |
US7494980B2 (en) * | 2003-03-10 | 2009-02-24 | The United States Of America As Represented By The Secretary Of The Army | Antimicrobial peptide and methods of use thereof |
US8778889B2 (en) * | 2003-03-10 | 2014-07-15 | The United States Of America As Represented By The Secretary Of The Army | Antimicrobial decapeptide oral hygiene treatment |
JP4880448B2 (ja) * | 2003-03-17 | 2012-02-22 | アフィナム ファーマシューティカルズ,インコーポレーテッド | 複数の抗生物質を含む組成物、及びそれを用いる方法 |
HUE045608T2 (hu) | 2003-06-06 | 2020-01-28 | Univ Texas | Antimikrobiális öblítõoldatok |
AU2004251823B2 (en) * | 2003-06-19 | 2010-06-03 | Janssen Pharmaceutica N.V. | Aminosulfonyl substituted 4-(aminomethyl)-piperidine benzamides as 5HT4-antagonists |
US20050214376A1 (en) * | 2003-10-21 | 2005-09-29 | Marie-Pierre Faure | Hydrogel-containing medical articles and methods of using and making the same |
US20050125015A1 (en) * | 2003-12-04 | 2005-06-09 | Mcnally-Heintzelman Karen M. | Tissue-handling apparatus, system and method |
US20050125033A1 (en) * | 2003-12-04 | 2005-06-09 | Mcnally-Heintzelman Karen M. | Wound closure apparatus |
US20050197634A1 (en) * | 2004-01-20 | 2005-09-08 | Board Of Regents, The University Of Texas System | Methods for coating and impregnating medical devices with antiseptic compositions |
US7597885B2 (en) * | 2004-03-26 | 2009-10-06 | Aderans Research Institute, Inc. | Tissue engineered biomimetic hair follicle graft |
US20050220821A1 (en) * | 2004-03-31 | 2005-10-06 | Allergan, Inc. | Pressure sore treatment |
ES2515101T3 (es) * | 2004-06-04 | 2014-10-29 | Debiopharm International Sa | Derivados de acrilamida como agentes antibióticos |
AR050212A1 (es) * | 2004-08-13 | 2006-10-04 | Aderans Res Inst Inc | Organogenesis a partir de celulas disociadas |
US20060115782A1 (en) * | 2004-11-30 | 2006-06-01 | Chunhua Li | Systems and methods for coating a dental appliance |
US7947508B2 (en) * | 2004-11-30 | 2011-05-24 | Align Technology, Inc. | Systems and methods for intra-oral diagnosis |
US7766658B2 (en) * | 2004-11-30 | 2010-08-03 | Align Technology, Inc. | Systems and methods for intra-oral diagnosis |
US20060115785A1 (en) * | 2004-11-30 | 2006-06-01 | Chunhua Li | Systems and methods for intra-oral drug delivery |
WO2006064381A2 (en) * | 2004-12-10 | 2006-06-22 | Straumann Holding Ag | Protein formulation |
SE0403014D0 (sv) * | 2004-12-10 | 2004-12-10 | Straumann Holding Ag | New protein formulation |
WO2006126096A2 (en) * | 2005-04-09 | 2006-11-30 | Makoto Fukae | Effect of porcinesheath proteins on the regeneration activity of periodontal ligament |
US20070048344A1 (en) * | 2005-08-31 | 2007-03-01 | Ali Yahiaoui | Antimicrobial composition |
US20070048356A1 (en) * | 2005-08-31 | 2007-03-01 | Schorr Phillip A | Antimicrobial treatment of nonwoven materials for infection control |
US20070048358A1 (en) * | 2005-08-31 | 2007-03-01 | Schorr Phillip A | Antimicrobial substrates |
US20070048345A1 (en) * | 2005-08-31 | 2007-03-01 | Kimberly-Clark Worldwide, Inc. | Antimicrobial composition |
WO2007062306A2 (en) | 2005-11-18 | 2007-05-31 | The Board Of Regents Of The University Of Texas System | Methods for coating surfaces with antimicrobial agents |
US20070148138A1 (en) * | 2005-11-22 | 2007-06-28 | Aderans Research Institute, Inc. | Hair follicle graft from tissue engineered skin |
TW200803877A (en) * | 2005-11-22 | 2008-01-16 | Aderans Res Inst Inc | Hair grafts derived from plucked hair |
US20090156578A1 (en) * | 2005-12-05 | 2009-06-18 | PAULS Henry | 3-Heterocyclylacrylamide Compounds as Fab I Inhibitors and Antibacterial Agents |
US20070135706A1 (en) * | 2005-12-13 | 2007-06-14 | Shimko Daniel A | Debridement method, device and kit |
US20070148187A1 (en) * | 2005-12-27 | 2007-06-28 | Intact Enterprises, Inc. | Mastic gum composition for use as a dietary supplement in humans and animals |
US8685421B2 (en) * | 2006-07-07 | 2014-04-01 | Surmodics, Inc. | Beaded wound spacer device |
WO2008009122A1 (en) | 2006-07-20 | 2008-01-24 | Affinium Pharmaceuticals, Inc. | Acrylamide derivatives as fab i inhibitors |
US7772213B2 (en) * | 2006-07-27 | 2010-08-10 | Nathan Strick | Composition for the treatment of inflammatory conditions |
US8623842B2 (en) * | 2006-09-27 | 2014-01-07 | Hemostasis, Llc | Hemostatic agent and method |
EP2125802A4 (en) * | 2007-02-16 | 2014-08-20 | Debiopharm Int Sa | SALTS, PRODRUGS AND POLYMORPHES OF FAB I INHIBITORS |
CA2678873C (en) | 2007-02-19 | 2016-10-25 | Plurogen Therapeutics, Inc. | Compositions for treating biofilms and methods for using same |
US7985537B2 (en) * | 2007-06-12 | 2011-07-26 | Aderans Research Institute, Inc. | Methods for determining the hair follicle inductive properties of a composition |
US20090202609A1 (en) * | 2008-01-06 | 2009-08-13 | Keough Steven J | Medical device with coating composition |
BRPI1010639A2 (pt) * | 2009-05-13 | 2016-03-15 | Protein Delivery Solutions Llc | sistema farmacêutico para distribuição transmembrana |
CA2762770C (en) * | 2009-05-19 | 2017-09-05 | Plurogen Therapeutics, Inc. | Surface active agent compositions and methods for enhancing oxygenation, reducing bacteria and improving wound healing |
US9192626B2 (en) * | 2009-06-10 | 2015-11-24 | American Silver, Llc | Dental uses of silver hydrosol |
CN101991688A (zh) * | 2009-08-20 | 2011-03-30 | 徐荣祥 | 药物组合物在制备治疗糖尿病溃疡药物中的用途 |
US8790613B2 (en) * | 2010-02-24 | 2014-07-29 | Erachem Comilog, Inc. | Treated electrolytic manganese dioxide and method for its production |
CA2801332C (en) * | 2010-10-15 | 2016-08-23 | Straumann Holding Ag | New emd formulation comprising pga |
WO2012166626A1 (en) | 2011-05-27 | 2012-12-06 | University Of Washington Through Its Center For Commercialization | Reagents and methods for treating dental disease |
SI2861608T1 (sl) | 2012-06-19 | 2019-08-30 | Debiopharm International Sa | Derivati predzdravila (E)-N-metil-N-((3-metilbenzofuran-2-IL)metil)- 3-(7-okso-5,6,7,8-tetrahidro-1 ,8-nafthiridin-3-il)akrilamid |
US20140023979A1 (en) * | 2012-07-18 | 2014-01-23 | Maha Mohamed Fouad Mounir | Regeneration of ameloblast cells and dental enamel in vivo |
JP6298468B2 (ja) | 2012-10-16 | 2018-03-20 | サーモディクス,インコーポレイテッド | 創傷充填デバイスおよび方法 |
US20140186273A1 (en) * | 2012-12-27 | 2014-07-03 | University Of Southern California | Chitosan -Amelogenin Hydrogel for In Situ Enamel Growth |
WO2014159623A2 (en) * | 2013-03-14 | 2014-10-02 | Nevins Alan | Root canal for tissue in-growth |
EP3001810B1 (en) * | 2013-04-30 | 2020-03-11 | Straumann Holding AG | Trap 63 |
US20160324728A1 (en) * | 2014-01-17 | 2016-11-10 | Straumann Holding Ag | Process for Producing EMD of Increased Stability |
US10201457B2 (en) | 2014-08-01 | 2019-02-12 | Surmodics, Inc. | Wound packing device with nanotextured surface |
US9238090B1 (en) | 2014-12-24 | 2016-01-19 | Fettech, Llc | Tissue-based compositions |
AU2016209327A1 (en) | 2015-01-20 | 2017-08-10 | Plurogen Therapeutics, Llc | Compositions and methods of treating microbes |
US9962465B2 (en) | 2015-07-07 | 2018-05-08 | University Of Southern California | Amelogenin-chitosan hydrogel for dentin hypersensitivity |
US10952940B2 (en) | 2016-01-15 | 2021-03-23 | University Of Washington | Reagents and methods for mineralization of tooth enamel |
BR112018015232A2 (pt) | 2016-01-31 | 2018-12-26 | Mediwound Ltd. | composição de desbridamento para tratar feridas |
CA3014541A1 (en) | 2016-02-26 | 2017-08-31 | Debiopharm International S.A. | Medicament for treatment of diabetic foot infections |
ES2936404T3 (es) * | 2016-04-18 | 2023-03-16 | Mediwound Ltd | Formulaciones para el desbridamiento de heridas crónicas |
US11457996B2 (en) * | 2019-09-12 | 2022-10-04 | King Abdulaziz University | Dental pulp capping composition and method of preserving and regenerating capped pulp and dentin bridge |
EP4262748A1 (en) * | 2020-12-21 | 2023-10-25 | Biointelligent Technology Systems SLU | A mucosal re-epithelialization composition |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE454480B (sv) | 1986-09-25 | 1988-05-09 | Lars Hammarstrom | Bindningsinducerande komposition |
SE461313B (sv) | 1988-03-17 | 1990-02-05 | Biora Ab | Bindningsinducerande komposition |
SE503096C2 (sv) | 1994-09-22 | 1996-03-25 | Biora Ab | Komposition innehållande EDTA för användning vid konditionering av tandrötter |
WO1997002730A2 (en) | 1995-07-13 | 1997-01-30 | Biora Ab | Enamel matrix related polypeptide |
-
1999
- 1999-02-26 JP JP2000533139A patent/JP4726296B2/ja not_active Expired - Lifetime
- 1999-02-26 RU RU2000124523/15A patent/RU2241489C2/ru active
- 1999-02-26 US US09/258,613 patent/US6503539B2/en not_active Expired - Lifetime
- 1999-02-26 BR BRPI9908182A patent/BRPI9908182C1/pt unknown
- 1999-02-26 PL PL382480A patent/PL204797B1/pl unknown
- 1999-03-02 AR ARP990100872A patent/AR020055A1/es unknown
-
2002
- 2002-05-28 US US10/156,300 patent/US6720009B2/en not_active Expired - Lifetime
-
2003
- 2003-10-30 US US10/698,618 patent/US7294352B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US7294352B2 (en) | 2007-11-13 |
US20030064927A1 (en) | 2003-04-03 |
JP4726296B2 (ja) | 2011-07-20 |
US6720009B2 (en) | 2004-04-13 |
RU2241489C2 (ru) | 2004-12-10 |
BRPI9908182B8 (pt) | 2018-08-14 |
BRPI9908182C1 (pt) | 2021-05-25 |
JP2002504520A (ja) | 2002-02-12 |
US20020169105A1 (en) | 2002-11-14 |
US6503539B2 (en) | 2003-01-07 |
BRPI9908182B1 (pt) | 2017-09-26 |
PL204797B1 (pl) | 2010-02-26 |
US20050271604A1 (en) | 2005-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR020055A1 (es) | Una composicion farmaceutica o cosmetica que contiene una sustancia de esmalte activa, usos de dicha composicion y un metodo para preparar la misma. | |
ES2120274T3 (es) | Utilizacion de un extracto de una bacteria filamentosa no fotosintetica y composicion. | |
ATE220918T1 (de) | Matrixprotein enthaltende zusammensetzungen zur wundheilung | |
ATE316786T1 (de) | Behandlung von mukositis | |
BR0207760A (pt) | Composição farmacêutica, uso da mesma, métodos para o tratamento de dor e de inflamação, e, processo para a preparação de uma composição | |
BR0015604A (pt) | Método para o tratamento de cicatrizes hipertróficas de modo a reduzir o tamanho e/ou melhorar a aparência das mesmas, composições para tratar condições adversas da pele, e, para reduzir o tamanho e melhorar a aparência de cicatrizes hipertróficas | |
DE60103894D1 (de) | Sprühfähige wundversorgungszusammensetzung | |
ES2181017T3 (es) | Composicion farmaceutica que contiene una sustancia promotora de osteogenesis y un polietilenglicol. | |
AU2001274374A1 (en) | Matrix protein compositions for dentin regeneration | |
ES2102284T3 (es) | Composicion cosmetica que comprende una asociacion de ceramidas y su utilizacion. | |
AR003001A1 (es) | Composicion farmaceutica estimuladora de la osteogenesis. | |
DK1165102T3 (da) | Matrixproteinpræparater til podning i ikke-mineraliseret væv | |
UY26514A1 (es) | " composición para el tratamiento de tejidos danados". | |
DE60135454D1 (de) | Pharmazeutische gel-zusammensetzung | |
BR0014751A (pt) | Composto, estereoisÈmero ou mistura de estereoisÈmeros, composição farmacêutica, método de tratamento de um paciente em necessidade de tratamento antimicrobiano, e, uso de um composto | |
EP1361905B8 (en) | Matrix protein compositions for guided connective tissue growth | |
BR0016646A (pt) | Método para tratar um paciente que sofre de dor, e, composição farmacêutica | |
AR004181A1 (es) | El uso de porfirinas verdes para preparar una composicion farmaceutica para tratar desordenes del endometrio o para la esterilizacion y composicionesfarmaceuticas que las contienen. | |
AR027984A1 (es) | Composicion para la higiene bucal que comprende clorhexidina como agente antibacteriano cationico para combatir la halitosis; uso de la clorhexidina para preparar dichas composiciones y procedimiento para tratar la halitosis, utilizando dichas composiciones para la higiene bucal | |
UY24489A1 (es) | Compuestos de dimetil-(3-aril-but-3-enil)-amina, procedimiento para su preparación y aplicación de estos compuestos en medicamentos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |